Foresight Group LTD Liability Partnership Astrazeneca PLC Transaction History
Foresight Group LTD Liability Partnership
- $670 Billion
- Q3 2025
A detailed history of Foresight Group LTD Liability Partnership transactions in Astrazeneca PLC stock. As of the latest transaction made, Foresight Group LTD Liability Partnership holds 171,086 shares of AZN stock, worth $15.3 Million. This represents 1.96% of its overall portfolio holdings.
Number of Shares
171,086
Previous 195,892
12.66%
Holding current value
$15.3 Million
Previous $27.2 Billion
51.68%
% of portfolio
1.96%
Previous 3.85%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,497Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...